Vigil Neuroscience, Inc.
VIGLDelisted Aug 5, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827087
Vigil Neuroscience, Inc. was delisted on Aug 5, 2025; its insiders filed their last Form 4 on Aug 7, 2025; 78 institutions reported holding it in 13F filings for Q2 2025, worth $265.8M in total; no superinvestor held it.
13F holders, Q2 2024
Institutional positions in Vigil Neuroscience, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 58
- +4 vs. Q1 2024
- Shares held
- 26.1M
- −385.3K (−1.5%) vs. Q1 2024
- Total value
- $104.5M
- +$14.0M (+15.4%) vs. Q1 2024
- New holders
- 20
- 13 more added
- Sold out
- 16
- 17 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VIGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 2 | $4.55K |
| Q2 2025 | 78 | $265.8M |
| Q1 2025 | 50 | $44.5M |
| Q4 2024 | 51 | $38.4M |
| Q3 2024 | 52 | $94.2M |
| Q2 2024 | 58 | $104.5M |
| Q1 2024 | 54 | $90.5M |
| Q4 2023 | 46 | $84.4M |
| Q3 2023 | 45 | $137.7M |
| Q2 2023 | 47 | $242.1M |
| Q1 2023 | 41 | $245.4M |
| Q4 2022 | 37 | $312.3M |
| Q3 2022 | 33 | $222.7M |
| Q2 2022 | 35 | $44.6M |
| Q1 2022 | 47 | $125.1M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Vigil Neuroscience, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,836,874 | $23.3M | 2.46% | 00.0% | Unchanged |
| Northpond Ventures, LLC | 4,214,498 | $16.9M | 30.50% | 00.0% | Unchanged |
| Artal Group S.A. | 1,828,691 | $7.31M | 0.19% | +17,500+1.0% | Added |
| BVF Inc | 1,813,633 | $7.25M | 0.20% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 1,692,166 | $6.77M | 1.10% | −38,248−2.2% | Reduced |
| Point72 Asset Management, L.P. | 1,485,000 | $5.94M | 0.02% | +1,485,000 | New |
| Citadel Advisors LLC | 1,443,159 | $5.77M | 0.01% | −722,652−33.4% | Reduced |
| 683 Capital Management, LLC | 1,100,000 | $4.40M | 0.46% | +105,100+10.6% | Added |
| Vanguard Group Inc | 814,731 | $3.26M | 0.00% | −79,742−8.9% | Reduced |
| StemPoint Capital LP | 744,412 | $2.98M | 0.88% | +744,412 | New |
| Deep Track Capital, LP | 597,215 | $2.39M | 0.07% | −997,716−62.6% | Reduced |
| Pivotal bioVenture Partners Investment Advisor LLC | 560,595 | $2.24M | 1.72% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 471,958 | $1.89M | 0.06% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 448,891 | $1.80M | 0.04% | 00.0% | Unchanged |
| BlackRock Inc. | 405,043 | $1.62M | 0.00% | −471,989−53.8% | Reduced |
| Goldman Sachs Group Inc | 401,139 | $1.60M | 0.00% | +382,900+2,099.3% | Added |
| Ensign Peak Advisors, Inc | 395,116 | $1.58M | 0.00% | +166,442+72.8% | Added |
| Millennium Management LLC | 334,807 | $1.34M | 0.00% | +301,678+910.6% | Added |
| ArrowMark Colorado Holdings LLC | 289,460 | $1.16M | 0.01% | 00.0% | Unchanged |
| Woodline Partners LP | 206,614 | $826.5K | 0.01% | +206,614 | New |
| Geode Capital Management, LLC | 159,371 | $637.6K | 0.00% | −174,871−52.3% | Reduced |
| Northern Trust Corp | 133,603 | $534.4K | 0.00% | −5,117−3.7% | Reduced |
| Bridgeway Capital Management, LLC | 80,064 | $320.3K | 0.01% | +22,100+38.1% | Added |
| Renaissance Technologies LLC | 71,500 | $286.0K | 0.00% | +11,536+19.2% | Added |
| Jane Street Group, LLC | 62,354 | $249.4K | 0.00% | +62,354 | New |
| Susquehanna International Group, LLP | 48,051 | $192.2K | 0.00% | +48,051 | New |
| Alpine Global Management, LLC | 44,893 | $179.6K | 0.03% | +44,893 | New |
| Barclays PLC | 44,755 | $179.0K | 0.00% | −68,281−60.4% | Reduced |
| PEAK6 Investments LLC | 41,486 | $165.9K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 40,739 | $163.0K | 0.00% | −245,324−85.8% | Reduced |
| Y-Intercept (Hong Kong) Ltd | 38,364 | $153.5K | 0.01% | +38,364 | New |
| Centiva Capital, LP | 32,800 | $131.2K | 0.01% | +32,800 | New |
| Qube Research & Technologies Ltd | 30,429 | $121.7K | 0.00% | +30,429 | New |
| Walleye Capital LLC | 27,575 | $110.3K | 0.00% | +27,575 | New |
| Bank of America Corp | 26,797 | $107.2K | 0.00% | +7,858+41.5% | Added |
| Point72 Asia (Singapore) Pte. Ltd. | 21,854 | $87.4K | 0.02% | +21,854 | New |
| Royal Bank of Canada | 20,455 | $82.0K | 0.00% | +20,088+5,473.6% | Added |
| Morgan Stanley | 19,841 | $79.4K | 0.00% | −3,521−15.1% | Reduced |
| Paloma Partners Management Co | 16,609 | $66.4K | 0.01% | +16,609 | New |
| Two Sigma Investments, LP | 12,065 | $48.3K | 0.00% | −32,933−73.2% | Reduced |
| Tower Research Capital LLC (TRC) | 11,765 | $47.1K | 0.00% | +5,976+103.2% | Added |
| Prelude Capital Management, LLC | 10,867 | $43.5K | 0.00% | −9,510−46.7% | Reduced |
| JPMorgan Chase & Co | 9,137 | $36.5K | 0.00% | +2,021+28.4% | Added |
| Mirae Asset Global ETFs Holdings Ltd. | 8,135 | $32.5K | 0.00% | +8,135 | New |
| Acadian Asset Management LLC | 6,598 | $26.0K | 0.00% | +6,598 | New |
| Point72 (DIFC) Ltd | 5,506 | $22.0K | 0.00% | +5,506 | New |
| UBS Group AG | 4,808 | $19.2K | 0.00% | −11,343−70.2% | Reduced |
| Catalyst Funds Management Pty Ltd | 4,100 | $16.4K | 0.00% | +4,100 | New |
| Cubist Systematic Strategies, LLC | 3,653 | $14.6K | 0.00% | +3,653 | New |
| FMR LLC | 2,896 | $11.6K | 0.00% | +1,246+75.5% | Added |
| Rhumbline Advisers | 2,588 | $10.4K | 0.00% | −15,365−85.6% | Reduced |
| Citigroup Inc | 2,411 | $9.64K | 0.00% | −64,899−96.4% | Reduced |
| Russell Investments Group, Ltd. | 2,029 | $8.12K | 0.00% | +2,029 | New |
| Macquarie Group Ltd | 831 | $3.32K | 0.00% | +831 | New |
| Federated Hermes, Inc. | 198 | $792 | 0.00% | −119−37.5% | Reduced |
| New York State Common Retirement Fund | 140 | $560 | 0.00% | −10,000−98.6% | Reduced |
| Nisa Investment Advisors, LLC | 75 | $300 | 0.00% | +75 | New |
| CWM, LLC | 16 | $0 | 0.00% | +15+1,500.0% | Added |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −980,311−100.0% | Sold out |
| DAFNA Capital Management LLC | 0 | $0 | 0.00% | −71,815−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −33,368−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −45,750−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −41,968−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −26,840−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −24,100−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −19,178−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −7,919−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −7,700−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −5,655−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −1,554−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −1,327−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −542−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |